We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
Extrusion Plant
(Site Profile/Docket Number 108)
Location: Ashtabula, Ohio
Also Known As: Reactive Metals, Inc., RMI
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from the Extrusion Plant.
Technical Documents
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Site Profile
-
Summary of Extrusion Plant Site Information for Dose Reconstruction [2.8 MB (86 pages)]
Revised March 7, 2017Revision Includes: Incorporates a rewrite of Section 3.0 – Occupational Medical X-rays, based on revisions to ORAUT-OTIB-0079, Rev. 01, Guidance on Assigning Occupational X Ray Dose Under EEOICPA for X-Rays Administered Off Site, and ORAUT-OTIB-0006, Rev. 04, Dose Reconstruction from Occupational Medical X-Ray Procedures. Revised Section 4.0 – Unmonitored and Environmental Dose, based on 2016 internal ORAUT and NIOSH comments for unmonitored and environmental dose. Revised Section 5.0 – Internal Dose, for referencing the Fernald Internal Dosimetry TBD section for recycled uranium. Revises neutron discussion, and resolved NIOSH comments from 2008 and 2016 to incorporate the external dosimetry data evaluation in Section 6.0 – External Dose. Revises Attachment E – External Data Evaluation of Doses, to give the 95th and 50th percentile doses to be used for unmonitored workers. Constitutes a total rewrite of the document.
Program Evaluation Plans (PEPs) and Program Evaluation Reports (PERs)
NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.
-
DCAS-PER-078, Rev. 0: Extrusion Plant TBD Revision Program Evaluation Report [220 KB (2 pages)]
January 4, 2018About this Document: Determines the effect of revision 1 to ORAUT-TKBS-0056 (Extrusion Plant TBD) on previously completed claims.
Summary: All claims resulted in a new POC below 45%. NIOSH will provide the Department of Labor with the list of all the claims evaluated under this PER. Since none of the claims would now result in a probability of causation greater than 50%, NIOSH will not request the return of any of these claims.
Public Comments on the Extrusion Plant Documents
How to Submit Comments
Comments on the Extrusion Plant documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:
NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226
Please include the Site Profile/Docket Number (108) on all comments.
Comments Received
At this time, no comments have been submitted.
Document Archive for the Extrusion Plant
- Site Profile: Summary of Extrusion Plant Site Information for Dose Reconstruction